We provide you with 20 years of free, institutional-grade data for PLSE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PLSE. Explore the full financial landscape of PLSE stock.
Total insider purchase within 3 month on this page: $26,590,675
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| DUGGAN ROBERT W | Open Market Purchase | 660,233 | $19.69 | 2026-05-15 | |
| LAVIOLETTE PAUL A | Open Market Purchase | 30,000 | $19.69 | 2026-05-11 | |
| DUGGAN ROBERT W | Open Market Purchase | 660,233 | $19.69 | 2026-05-11 | |
| Danahy Kevin Patrick | Sale | -5,000 | $23.64 | $118,200 | 2026-02-23 |
| Danahy Kevin Patrick | Derivatives Exercise | 5,000 | 2026-02-23 | ||
| Danahy Kevin Patrick | Sale | -60,000 | $23.37 | $1,402,200 | 2026-02-17 |
| Danahy Kevin Patrick | Derivatives Exercise | 60,000 | 2026-02-17 | ||
| Danahy Kevin Patrick | Sale | -60,000 | $21.45 | $1,287,000 | 2026-02-11 |
| Danahy Kevin Patrick | Derivatives Exercise | 60,000 | 2026-02-11 | ||
| Danahy Kevin Patrick | Sale | -4,600 | $18.53 | $85,238 | 2025-10-07 |
| Danahy Kevin Patrick | Derivatives Exercise | 4,600 | 2025-10-07 | ||
| Danahy Kevin Patrick | Sale | -20,400 | $18.49 | $377,196 | 2025-09-22 |
| Danahy Kevin Patrick | Derivatives Exercise | 20,400 | 2025-09-22 | ||
| UECKER DARRIN | Sale | -45,000 | $16.28 | $732,600 | 2025-09-18 |
| UECKER DARRIN | Derivatives Exercise | 206,534 | 2025-09-18 | ||
| UECKER DARRIN | Sale | -75,000 | $14.78 | $1,108,500 | 2025-09-15 |
| UECKER DARRIN | Derivatives Exercise | 75,000 | 2025-09-15 | ||
| DUGGAN ROBERT W | Open Market Purchase | 192,599 | $14.66 | 2025-09-12 | |
| UECKER DARRIN | Sale | -30,000 | $16.4 | $492,000 | 2025-06-16 |
| Barrett Burke Thomas | Sale | -50,000 | $17.42 | $871,000 | 2024-12-20 |
| DUGGAN ROBERT W | Open Market Purchase | 100,660 | $17.13 | 2024-12-17 | |
| DUGGAN ROBERT W | Open Market Purchase | 56,054 | $16.74 | 2024-12-13 | |
| Barrett Burke Thomas | Open Market Purchase | 10,000 | $8.56 | 2024-05-22 | |
| DUGGAN ROBERT W | Open Market Purchase | 17,999 | $9.15 | 2023-12-14 | |
| DUGGAN ROBERT W | Open Market Purchase | 90,118 | $9.36 | 2023-12-13 | |
| DUGGAN ROBERT W | Open Market Purchase | 116,656 | $9.54 | 2023-12-12 | |
| DUGGAN ROBERT W | Open Market Purchase | 74,852 | $9.19 | 2023-12-11 | |
| DUGGAN ROBERT W | Open Market Purchase | 82,813 | $9.06 | 2023-12-08 | |
| DUGGAN ROBERT W | Derivatives Exercise | 9,933 | 2023-12-08 | ||
| DUGGAN ROBERT W | Open Market Purchase | 66,021 | $9.34 | 2023-12-07 | |
| DUGGAN ROBERT W | Open Market Purchase | 27,000 | $10.38 | 2023-12-06 | |
| DUGGAN ROBERT W | Derivatives Exercise | 40,347 | 2023-12-06 | ||
| DUGGAN ROBERT W | Open Market Purchase | 45,600 | $9.07 | 2023-12-05 | |
| DUGGAN ROBERT W | Open Market Purchase | 152,944 | $9.06 | 2023-12-04 | |
| DUGGAN ROBERT W | Open Market Purchase | 60,000 | $9.21 | 2023-12-01 | |
| DUGGAN ROBERT W | Open Market Purchase | 158,600 | $9.44 | 2023-12-01 | |
| DUGGAN ROBERT W | Derivatives Exercise | 1,667 | 2023-12-01 | ||
| DUGGAN ROBERT W | Open Market Purchase | 124,397 | $8.98 | 2023-11-30 | |
| DUGGAN ROBERT W | Open Market Purchase | 20,241 | $6.1 | 2023-11-20 | |
| Levinson Mitchell E. | Open Market Purchase | 1,039 | $6.13 | 2023-11-17 | |
| Levinson Mitchell E. | Open Market Purchase | 2,500 | $5.9 | 2023-11-17 | |
| Levinson Mitchell E. | Open Market Purchase | 2,500 | $5.94 | 2023-11-17 | |
| Levinson Mitchell E. | Open Market Purchase | 2,500 | $5.92 | 2023-11-17 | |
| Levinson Mitchell E. | Open Market Purchase | 5,000 | $5.94 | 2023-11-17 | |
| Levinson Mitchell E. | Open Market Purchase | 4,261 | $5.83 | 2023-11-17 | |
| Danahy Kevin Patrick | Open Market Purchase | 5,393 | $6.52 | 2023-11-17 | |
| Zanganeh Mahkam | Derivatives Exercise | 76,075 | 2023-11-15 | ||
| DUGGAN ROBERT W | Derivatives Exercise | 13,265 | 2023-11-09 | ||
| DUGGAN ROBERT W | Derivatives Exercise | 1,667 | 2023-08-28 | ||
| DUGGAN ROBERT W | Derivatives Exercise | 1,667 | 2023-07-27 | ||
| DUGGAN ROBERT W | Derivatives Exercise | 132,133 | 2023-07-07 |
The information provided in this report about PLSE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Pulse Biosciences, Inc(NASDAQ:PLSE) 
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue p...
Website: http://www.pulsebiosciences.com
Founded: 2014
Full Time Employees: 82
Sector: Healthcare
Industry: Medical Instruments & Supplies